Companies / Climb Bio, Inc. / Activity
Activity — Climb Bio, Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Thomas Stephen Basil Director | Sell | Common Stock | $471.0K | -90K -29.54% | 214,657 0.37% of shares | medium |
| Feb 25, 2026 | Thomas Stephen Basil Director | Sell | Common Stock | $236.0K | -34K -16.46% | 170,970 0.30% of shares | medium |
| Feb 26, 2026 | Thomas Stephen Basil Director | Sell | Common Stock | $114.3K | -16K -9.54% | 154,657 0.27% of shares | medium |
| Feb 13, 2026 | Thomas Stephen Basil Director | Sell | Common Stock | $58.1K | -10K -4.66% | 204,657 0.36% of shares | low |
| Jan 5, 2026 | RA Capital Management, L.P. Director | Buy | Common Stock | $24.9K | +7K +0.21% | 3,403,429 5.93% of shares | low |
| Jun 5, 2026 | Drapkin Kimberlee C Director | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.07% of shares | low |
| Jun 5, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.07% of shares | low |
| Apr 29, 2026 | RA Capital Management, L.P. Director | Grant | Pre-Funded Warrants (Right to Buy) | — | +2.1M +10.30% | 22,546,000 39.25% of shares | low |
| Jun 5, 2026 | Williams Douglas E Director | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.07% of shares | low |
| Jan 6, 2026 | ALTSCHULLER Susan Executive | Grant | Stock Option (Right to Buy) | — | +143K | 142,500 0.25% of shares | low |
| Jan 6, 2026 | Brennan Aoife CEO | Grant | Stock Option (Right to Buy) | — | +700K | 700,000 1.22% of shares | low |
| Jan 6, 2026 | Wilson Perrin Megan Executive | Grant | Stock Option (Right to Buy) | — | +300K | 300,000 0.52% of shares | low |
| Jan 6, 2026 | Driscoll Cindy Executive | Grant | Stock Option (Right to Buy) | — | +100K | 100,000 0.17% of shares | low |